Eisai (ESALY) and its partner Biogen (NASDAQ:BIIB) presented the full Phase 3 lecanemab (newest Alzheimer’s drug) data. In response, H.C. Wainwright analyst Andrew Fein stated, “The totality of the lecanemab data might
Eisai (ESALY) and its partner Biogen (NASDAQ:BIIB) presented the full Phase 3 lecanemab (newest Alzheimer’s drug) data. In response, H.C. Wainwright analyst Andrew Fein stated, “The totality of the lecanemab data might
While electric vehicles (EVs) are witnessing increased adoption amid growing environmental concerns and favorable policies, many startups in the EV space have lost substantial value and are trading as penny stocks,
Intellia Therapeutics (NASDAQ:NTLA) stock closed 7.2% higher on November 30. However, shares of this clinical-stage biotech company are down 3.8% in the pre-market session on December 1, following the pricing
Hewlett Packard Enterprise (NYSE:HPE), an edge-to-cloud platform-as-a-service company, has expressed interest in acquiring Nutanix (NASDAQ:NTNX), Bloomberg reported, citing people familiar with the matter. However, the report highlighted that these companies have yet
Last updated: 9:44AM EST Shares of Horizon Therapeutics (NASDAQ:HZNP) were up about 28% in the morning trading session on November 30 on takeover interest from large pharma companies. The biopharmaceutical
